314 related articles for article (PubMed ID: 19381116)
21. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
22. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
[TBL] [Abstract][Full Text] [Related]
23. [Effect of iodine application during radioiodine therapy in patients with impending therapy failure].
Urbannek V; Schmidt M; Moka D; Hillger HW; Voth E; Wellner U; Schicha H
Nuklearmedizin; 2000; 39(4):108-12. PubMed ID: 10919161
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy (I 131).
Khanna CM; Magdum M; Ravishankar L; Dham DN; Chugh P
J Assoc Physicians India; 1996 Feb; 44(2):102-5. PubMed ID: 10999060
[TBL] [Abstract][Full Text] [Related]
25. [Iodine uptake and the effect of radioiodine treatment--status after the addition of iodine to salt].
Vej-Hansen A; Nygaard B
Ugeskr Laeger; 2005 Sep; 167(39):3684-7. PubMed ID: 16219216
[TBL] [Abstract][Full Text] [Related]
26. External dose rates in radioiodine treatment of benign goitre: estimation versus direct measurement.
Jørgensen HB; Høilund-Carlsen PF; Nielsen VE
Scand J Clin Lab Invest; 2006; 66(6):509-16. PubMed ID: 17000558
[TBL] [Abstract][Full Text] [Related]
27. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study.
Peters H; Fischer C; Bogner U; Reiners C; Schleusener H
Eur J Clin Invest; 1996 Jan; 26(1):59-63. PubMed ID: 8682157
[TBL] [Abstract][Full Text] [Related]
28. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation.
Grewal RK; Larson SM; Pentlow CE; Pentlow KS; Gonen M; Qualey R; Natbony L; Tuttle RM
J Nucl Med; 2009 Oct; 50(10):1605-10. PubMed ID: 19759114
[TBL] [Abstract][Full Text] [Related]
29. [Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].
Krohn T; Meyer PT; Ocklenburg C; Knollmann D; Nowak B; Schaefer WM
Nuklearmedizin; 2008; 47(6):248-54. PubMed ID: 19057798
[TBL] [Abstract][Full Text] [Related]
30. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen WJ; Goecke J; Pfestroff A; Schlieck A; Corstens FH; Béhé M; Behr TM
Nuklearmedizin; 2006; 45(5):206-12. PubMed ID: 17043731
[TBL] [Abstract][Full Text] [Related]
31. Radioiodine treatment of hyperthyroidism in a pregnant women.
Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
[TBL] [Abstract][Full Text] [Related]
32. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
[TBL] [Abstract][Full Text] [Related]
33. Unsuccessful radioiodine treatment of a non-toxic goiter: a case report.
Hartoft-Nielsen ML; Rasmussen AK; Friis E; Blichert-Toft M; Buhl T; Hesse B; Feldt-Rasmussen U
Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):72-5. PubMed ID: 15379783
[TBL] [Abstract][Full Text] [Related]
34. Influence of radioiodine therapy on urinary iodine excretion.
Meller B; Lauer I; Bähre M; Richter E
Nuklearmedizin; 1998 May; 37(3):107-12. PubMed ID: 9604231
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules.
Zingrillo M; Modoni S; Conte M; Frusciante V; Trischitta V
J Nucl Med; 2003 Feb; 44(2):207-10. PubMed ID: 12571210
[TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of goiter treatment with L-thyroxine in patients over 40].
Wollmann B; Meller J; Hüfner M; Becker W
Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169
[TBL] [Abstract][Full Text] [Related]
37. Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule.
Zakavi SR; Mousavi Z; Davachi B
Nucl Med Commun; 2009 Feb; 30(2):169-75. PubMed ID: 19194214
[TBL] [Abstract][Full Text] [Related]
38. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
Bonnema SJ; Nielsen VE; Hegedüs L
Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism.
Bal CS; Kumar A; Pandey RM
Thyroid; 2002 May; 12(5):399-405. PubMed ID: 12097201
[TBL] [Abstract][Full Text] [Related]
40. Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy.
Yano Y; Sugino K; Akaishi J; Uruno T; Okuwa K; Shibuya H; Kitagawa W; Nagahama M; Ito K; Ito K
Ann Nucl Med; 2011 Dec; 25(10):749-54. PubMed ID: 21971604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
